Purpose: Claudin 18.2 (CLDN18.2) has emerged as a promising therapeutic target for CLDN18.2-expressing gastric cancer (GC). We sought to examine the heterogeneity of CLDN18.2 expression between primary GC (PGC) and metastatic GC (MGC) using various scoring methods. Materials and Methods: We retrospectively analyzed data from 102 patients with pathologically confirmed paired primary and metastatic gastric or gastroesophageal junction adenocarcinomas. CLDN18.2 expression was evaluated through immunohistochemistry on formalin-fixed paraffin-embedded tissue samples. We assessed CLDN18.2 positivity using multiple scoring approaches, including the immunoreactivity score, H-score, and the percentage of tumor cells showing moderate-to-strong staining intensity. We analyzed the concordance rates between PGC and MGC and the association of CLDN18.2 positivity with clinicopathological features. Results: CLDN18.2 positivity varied from 25% to 65% depending on the scoring method, with PGC consistently showing higher expression levels than MGC. Intratumoral heterogeneity was noted in 25.5% of PGCs and 19.6% of MGCs. Intertumoral heterogeneity, manifesting as discordance in CLDN18.2 positivity between PGC and MGC, was observed in about 20% of cases, with moderate agreement across scoring methods (κ=0.47 to 0.60).In PGC, higher CLDN18.2 positivity correlated with synchronous metastasis, presence of peritoneal metastasis, poorly differentiated grade, and biopsy specimens. In MGC, positivity was associated with synchronous metastasis, presence of peritoneal metastasis, and metastatic peritoneal tissues. Conclusions CLDN18.2 expression demonstrates significant heterogeneity between PGC and MGC, with a 20% discordance rate. Comprehensive tissue sampling and reassessment of CLDN18.2 status are crucial, especially before initiating CLDN18.2-targeted therapies.

Background: Chromosomal alterations serve as diagnostic and prognostic markers in acute leukemia. Given the evolving landscape of chromosomal abnormalities in acute leukemia, we previously studied these over two periods. In this study, we investigated the frequency of these abnormalities and clinical trends in acute leukemia in Korea across three time periods. Methods: We retrospectively analyzed data from 1,787 patients with acute leukemia (319 children and 1,468 adults) diagnosed between 2006 and 2020. Conventional cytogenetics, FISH, and multiplex quantitative PCR were used for analysis. The patient groups were divided according to the following three study periods: 2006–2009 (I), 2010–2015 (II), and 2016–2020 (III). Results: Chromosomal aberrations were detected in 92% of patients. The PML::RARA translocation was the most frequent. Over the 15-yr period, chromosomal aberrations showed minimal changes, with specific fusion transcripts being common among patients.ALL was more prevalent in children than in adults and correlated significantly with the ETV6::RUNX1 and RUNX1::RUNX1T1 aberrations. The incidence of ALL increased during the three periods, with PML::RARA remaining common. Conclusions The frequency of chromosomal abnormalities in acute leukemia has changed subtly over time. Notably, the age of onset of adult AML has continuously increased. Our results may help in establishing diagnoses and clinical treatment strategies and developing various molecular diagnostic platforms.

This study aimed to investigate changes in candidemia incidence, species distribution, antifungal susceptibility, initial antifungal use, and mortality trends in Korea before and during the COVID-19 pandemic. A retrospective analysis was conducted on candidemia cases from two tertiary care hospitals in Korea between 2017 and 2022. Data were compared between the pre-pandemic (2017-2019) and pandemic (2020-2022) periods. Statistical methods included incidence rate ratios (IRRs) and multivariate Cox regression to assess 30-day mortality risk factors. A total of 470 candidemia cases were identified, with 48.7% occurring pre-pandemic and 51.3% during the pandemic. While the overall incidence of candidemia remained similar across the two periods (IRR 1.15;p=0.13), the incidence in intensive care units (ICUs) significantly increased during the pandemic (IRR 1.50; p<0.01). The distribution of Candida species did not differ significantly between the two periods. Fluconazole non-susceptibility in C. albicans markedly decreased (10.0% vs. 0.9%, p<0.01), whereas C. glabrata exhibited a significant rise in caspofungin non-susceptibility during the pandemic (0% vs. 22.4%, p<0.01).Echinocandin use increased (21.8% vs. 34.4%; p<0.01), while fluconazole use declined (48.0% vs. 32.8%; p<0.01). Although the 30-day mortality rate was higher during the pandemic (60.2% vs. 57.2%), the difference was not statistically significant (p=0.57).The findings highlight the need for region-specific surveillance and tailored management strategies to improve candidemia outcomes, especially during healthcare disruptions like the COVID-19 pandemic.

Purpose: This study aims to develop and test the psychometric properties of a scale for measuring the continuity of care specific to home health care patients in the context of Korean long-term care insurance services. Methods: In phase 1, the initial item pool was created based on the concept analysis results using a literature review and in-depth interviews. Phase 2 evaluated the psychometric properties of the scale in the survey conducted in 2021 using a sample of 202 receiving longterm care visiting nursing services. Exploratory factor analysis (EFA) was used to examine the construct validity. An internal consistency was examined using Cronbach’s α. Known group validity and criterion validity were assessed. Results: The EFA suggested five factors: therapeutic relationship, coordination of care, service availability, customized care plan, and consistency in service provision. The internal consistency reliability of the continuity of care scale was satisfactory (Cronbach’s α=.96). Known-group validity was established by comparing the continuity of care scores for high utilizers of home-visiting nursing services and low utilizers of home-visiting nursing services. Criterion validity was confirmed through the correlation between the developed scale and the performance of the visiting nurse service scale. Conclusion The developed scale was found to be reliable and relatively valid for measuring the patient’s perceived continuity of care within the Korean long-term care visiting nursing system.

Purpose: This study aims to develop and test the psychometric properties of a scale for measuring the continuity of care specific to home health care patients in the context of Korean long-term care insurance services. Methods: In phase 1, the initial item pool was created based on the concept analysis results using a literature review and in-depth interviews. Phase 2 evaluated the psychometric properties of the scale in the survey conducted in 2021 using a sample of 202 receiving longterm care visiting nursing services. Exploratory factor analysis (EFA) was used to examine the construct validity. An internal consistency was examined using Cronbach’s α. Known group validity and criterion validity were assessed. Results: The EFA suggested five factors: therapeutic relationship, coordination of care, service availability, customized care plan, and consistency in service provision. The internal consistency reliability of the continuity of care scale was satisfactory (Cronbach’s α=.96). Known-group validity was established by comparing the continuity of care scores for high utilizers of home-visiting nursing services and low utilizers of home-visiting nursing services. Criterion validity was confirmed through the correlation between the developed scale and the performance of the visiting nurse service scale. Conclusion The developed scale was found to be reliable and relatively valid for measuring the patient’s perceived continuity of care within the Korean long-term care visiting nursing system.

Purpose: This study aims to develop and test the psychometric properties of a scale for measuring the continuity of care specific to home health care patients in the context of Korean long-term care insurance services. Methods: In phase 1, the initial item pool was created based on the concept analysis results using a literature review and in-depth interviews. Phase 2 evaluated the psychometric properties of the scale in the survey conducted in 2021 using a sample of 202 receiving longterm care visiting nursing services. Exploratory factor analysis (EFA) was used to examine the construct validity. An internal consistency was examined using Cronbach’s α. Known group validity and criterion validity were assessed. Results: The EFA suggested five factors: therapeutic relationship, coordination of care, service availability, customized care plan, and consistency in service provision. The internal consistency reliability of the continuity of care scale was satisfactory (Cronbach’s α=.96). Known-group validity was established by comparing the continuity of care scores for high utilizers of home-visiting nursing services and low utilizers of home-visiting nursing services. Criterion validity was confirmed through the correlation between the developed scale and the performance of the visiting nurse service scale. Conclusion The developed scale was found to be reliable and relatively valid for measuring the patient’s perceived continuity of care within the Korean long-term care visiting nursing system.

This study aimed to investigate changes in candidemia incidence, species distribution, antifungal susceptibility, initial antifungal use, and mortality trends in Korea before and during the COVID-19 pandemic. A retrospective analysis was conducted on candidemia cases from two tertiary care hospitals in Korea between 2017 and 2022. Data were compared between the pre-pandemic (2017-2019) and pandemic (2020-2022) periods. Statistical methods included incidence rate ratios (IRRs) and multivariate Cox regression to assess 30-day mortality risk factors. A total of 470 candidemia cases were identified, with 48.7% occurring pre-pandemic and 51.3% during the pandemic. While the overall incidence of candidemia remained similar across the two periods (IRR 1.15;p=0.13), the incidence in intensive care units (ICUs) significantly increased during the pandemic (IRR 1.50; p<0.01). The distribution of Candida species did not differ significantly between the two periods. Fluconazole non-susceptibility in C. albicans markedly decreased (10.0% vs. 0.9%, p<0.01), whereas C. glabrata exhibited a significant rise in caspofungin non-susceptibility during the pandemic (0% vs. 22.4%, p<0.01).Echinocandin use increased (21.8% vs. 34.4%; p<0.01), while fluconazole use declined (48.0% vs. 32.8%; p<0.01). Although the 30-day mortality rate was higher during the pandemic (60.2% vs. 57.2%), the difference was not statistically significant (p=0.57).The findings highlight the need for region-specific surveillance and tailored management strategies to improve candidemia outcomes, especially during healthcare disruptions like the COVID-19 pandemic.